Zobrazeno 1 - 10
of 547
pro vyhledávání: '"Richard A, Baum"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Herein we report, for the first time, the therapeutic response of a prostate cancer patient with the thiamine antagonist benfo-oxythiamine (B-OT) added to prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (PRLT). The patient was
Externí odkaz:
https://doaj.org/article/26108a0865834d5a87dcf893a2d83a18
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/bccc26b5904843e6ae337aaacea06847
Autor:
Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, Frank Osterkamp, Christiane Smerling, Christian Landvogt, Corinna Mueller, Richard P. Baum
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108541- (2023)
Summary: Hardly any new tracers attracted more attention in nuclear medicine in the last couple of years than radiolabeled fibroblast activation protein inhibitors (FAPi’s). Molecules targeting cancer-associated fibroblasts (CAFs) or disease-associ
Externí odkaz:
https://doaj.org/article/8ff7f2035d1c4fc78234a014be25587e
Autor:
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, Richard P. Baum
Publikováno v:
Diagnostics, Vol 14, Iss 9, p 907 (2024)
The present report describes the history of a 58-year-old woman with a rapidly progressing neuroendocrine pancreatic tumor (initially G2) presenting with extensive liver, bone, and lymph node metastases. Previous treatments included chemotherapy, hem
Externí odkaz:
https://doaj.org/article/954bf3749ed14039a4459a0950bb60ba
Autor:
David Parker, Jessica Zambelli, Montana Kay Lara, Trevor Hamilton Wolf, Amber McDonald, Erica Lee, Lotfi Abou-Elkacem, Eva J. Gordon, Richard P. Baum
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Despite decades of research and clinical trials, metastatic castration-resistant prostate cancer (mCRPC) remains incurable and typically fatal. Current treatments may provide modest increases in progression-free survival but can come with significant
Externí odkaz:
https://doaj.org/article/60a5602afe16487e8e93a9a5fd4121e5
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/7831ea8b0c244da9b2930733232398ab
Autor:
Mengqi Shi, Vivianne Jakobsson, Lukas Greifenstein, Pek-Lan Khong, Xiaoyuan Chen, Richard P. Baum, Jingjing Zhang
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Peptide receptor radionuclide therapy (PRRT) has over the last two decades emerged as a very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding clinical applications. By chelating a radiometal to a somatostatin receptor (
Externí odkaz:
https://doaj.org/article/2bbd26c1e218460f83eba0de87ee8bb0
Autor:
Franziska Briest, Eva J. Koziolek, Jakob Albrecht, Fränze Schmidt, Monique R. Bernsen, Joost Haeck, Anja A. Kühl, Dagmar Sedding, Teresa Hartung, Samantha Exner, Martina Welzel, Christian Fischer, Carsten Grötzinger, Winfried Brenner, Richard P. Baum, Patricia Grabowski
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 1, Pp 80-98 (2021)
Background: Well-differentiated gastroenteropancreatic neuroendocrine neoplasms are rare tumors with a slow proliferation. They are virtually resistant to many DNA-damaging therapeutic approaches, such as chemo- and external beam therapy, which might
Externí odkaz:
https://doaj.org/article/ae7137f1c25a44b7a686f53aa5278365
Autor:
Cristina Müller, Aviral Singh, Christoph A. Umbricht, Harshad R. Kulkarni, Karl Johnston, Martina Benešová, Stefan Senftleben, Dirk Müller, Christiaan Vermeulen, Roger Schibli, Ulli Köster, Nicholas P. van der Meulen, Richard P. Baum
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background For almost a decade, terbium radioisotopes have been explored for their potential theragnostic application in nuclear medicine: 152Tb and 155Tb are the radioisotopes identified for PET or SPECT imaging, while 149Tb and 161Tb have
Externí odkaz:
https://doaj.org/article/7eda5b3c70fa41ca97364e47bb48a567
Autor:
Jean-Philippe Sinnes, Johannes Nagel, Bradley P. Waldron, Theodosia Maina, Berthold A. Nock, Ralf K. Bergmann, Martin Ullrich, Jens Pietzsch, Michael Bachmann, Richard P. Baum, Frank Rösch
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-11 (2019)
Abstract Purpose The widespread use of 68Ga for positron emission tomography (PET) relies on the development of radiopharmaceutical precursors that can be radiolabelled and dispensed in a simple, quick, and convenient manner. The DATA (6-amino-1,4-di
Externí odkaz:
https://doaj.org/article/5b332af26c614df9be3aaf1328b913a8